Literature DB >> 18815302

Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.

Claudia Bönsch1, Christoph Kempf, Carlos Ros.   

Abstract

The unique region of the capsid protein VP1 (VP1u) of B19 virus (B19V) elicits a dominant immune response and has a phospholipase A(2) (PLA(2)) activity required for the infection. Despite these properties, we have observed that the VP1u-PLA(2) motif occupies an internal position in the capsid. However, brief exposure to increasing temperatures induced a progressive accessibility of the PLA(2) motif as well as a proportional increase of the PLA(2) activity. Similarly, upon binding on human red blood cells (RBCs), a proportion of the capsids externalized the VP1u-PLA(2) motif. Incubation of B19V with RBCs from 17 healthy donors resulted in extensive virus attachment ranging between 3,000 and 30,000 virions per cell. B19V empty capsids represent an important fraction of the viral particles circulating in the blood (30 to 40%) and bind to RBCs in the same way as full capsids. The extensive B19V binding to RBCs did not cause direct hemolysis but an increased osmotic fragility of the cells by a mechanism involving the PLA(2) activity of the exposed VP1u. Analysis of a blood sample from an individual with a recent B19V infection revealed that, at this particular moment of the infection, the virions circulating in the blood were mostly associated to the RBC fraction. However, the RBC-bound B19V was not able to infect susceptible cells. These observations indicate that RBCs play a significant role during B19V infection by triggering the exposure of the immunodominant VP1u including its PLA(2) constituent. On the other hand, the early exposure of VP1u might facilitate viral internalization and/or uncoating in target cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815302      PMCID: PMC2583657          DOI: 10.1128/JVI.01399-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.

Authors:  E Zuffi; E Manaresi; G Gallinella; G A Gentilomi; S Venturoli; M Zerbini; M Musiani
Journal:  Viral Immunol       Date:  2001       Impact factor: 2.257

2.  The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.

Authors:  Simone Dorsch; Gerhard Liebisch; Bärbel Kaufmann; Philipp von Landenberg; Jörg H Hoffmann; Wolfgang Drobnik; Susanne Modrow
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection.

Authors:  Maija Vihinen-Ranta; Dai Wang; Wendy S Weichert; Colin R Parrish
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability.

Authors:  Simone Dorsch; Bärbel Kaufmann; Uwe Schaible; Elke Prohaska; Hans Wolf; Susanne Modrow
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

5.  The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.

Authors:  Anne Girod; Christiane E Wobus; Zoltán Zádori; Martin Ried; Kristin Leike; Peter Tijssen; Jürgen A Kleinschmidt; Michael Hallek
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

6.  A viral phospholipase A2 is required for parvovirus infectivity.

Authors:  Z Zádori; J Szelei; M C Lacoste; Y Li; S Gariépy; P Raymond; M Allaire; I R Nabi; P Tijssen
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

7.  Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.

Authors:  K A Weigel-Kelley; M C Yoder; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.

Authors:  Philipp Von Landenberg; Hartwig W Lehmann; Antje Knöll; Simone Dorsch; Susanne Modrow
Journal:  Arthritis Rheum       Date:  2003-07

9.  Complementary roles of multiple nuclear targeting signals in the capsid proteins of the parvovirus minute virus of mice during assembly and onset of infection.

Authors:  Eleuterio Lombardo; Juan C Ramírez; Javier Garcia; José M Almendral
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Parvovirus B19 infection in pregnancy.

Authors:  Joan Crane
Journal:  J Obstet Gynaecol Can       Date:  2002-09
View more
  18 in total

1.  Severe warm autoimmune haemolytic anaemia due to anti-Jk(a) autoantibody associated with Parvovirus B19 infection in a child.

Authors:  Gianluca Giovannetti; Simona Pauselli; Gianna Barrella; Alessia Neri; Loretta Antonetti; Giuseppe Gentile; Metello Iacobini; Gabriella Girelli; Serelina Coluzzi
Journal:  Blood Transfus       Date:  2013-03-14       Impact factor: 3.443

2.  Transient aplastic crisis in hereditary elliptocytosis.

Authors:  Prasanna K Kapavarapu; Amal Paul; A V Lalitha; Arun S Shet
Journal:  Indian J Pediatr       Date:  2012-12       Impact factor: 1.967

3.  Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.

Authors:  Jan Bieri; Carlos Ros
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  Characterization of the early steps of human parvovirus B19 infection.

Authors:  Silva Quattrocchi; Nico Ruprecht; Claudia Bönsch; Sven Bieli; Christoph Zürcher; Klaus Boller; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

5.  Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.

Authors:  Yingyuan Sun; Thomas Klose; Yue Liu; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

Review 6.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization.

Authors:  Claudia Bönsch; Christoph Zuercher; Patricia Lieby; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

8.  Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.

Authors:  Claudia Bönsch; Christoph Kempf; Ivo Mueller; Laurens Manning; Moses Laman; Timothy M E Davis; Carlos Ros
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

9.  Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.

Authors:  Remo Leisi; Nico Ruprecht; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

10.  Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors.

Authors:  Rabab Hasanain Ahmed Hasanain; Rania M Saleh; Fadia M Attia; Hanaa H Gomaa
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-22       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.